International Health Overview

Principles

Definition

International health is an academic and public health field focused on health issues that transcend national boundaries. It investigates global health challenges and inequities, aiming to improve health outcomes and strengthen health systems worldwide through international collaboration.

Ontological type

Core Themes

Key Actors

Policy Frameworks

Key developments

Key Figures

Standardized Global Surveillance era

Christopher J L Murray [1] is associated with Harvard University [3] and the University of California, Berkeley [4] during the Standardized Global Surveillance era (1965-1997). His key contributions in this era derive from the World development report 1993 : investing in health [7] and The global burden of disease in 1990: summary results, sensitivity analysis and future directions [8], which advanced internationally comparable health metrics and burden assessment, enabling cross-country comparisons and policy-relevant health governance. Dean T. Jamison [2] is associated with Stanford University [5] and Johns Hopkins University [6] in this era. His central contribution is the World development report 1993 : investing in health [7], underscoring the centrality of health investment for standardized surveillance and global health measurement during this era.

Global Burden Metrics era

Tim Cole [1] is a scholar associated with institutions such as École Polytechnique Fédérale de Lausanne [3] and Heidelberg University [4] during this era of burden estimates. His key contribution in the era was establishing a standard definition for child overweight and obesity worldwide, as described in the 2000 paper 'Establishing a standard definition for child overweight and obesity worldwide: international survey' [6], which helped standardize cross-country comparisons essential for burden estimation. Colin Mathers [2] at The University of Sydney [5] during this era. His contributions include Projections of Global Mortality and Burden of Disease from 2002 to 2030 [7] and Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data [8], which provided the foundational burden estimates and risk-factor profiles that guided policy and investment in this era.

Integrated Genomic Surveillance era

George F. Gao [1] is a leading figure whose work spans Baylor College of Medicine [3] and Beijing University of Chemical Technology [4] during the Integrated Genomic Surveillance era (2012-2024). His key contributions this era include co-authoring A Novel Coronavirus from Patients with Pneumonia in China, 2019 [7] and Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia [8], which provided the rapid genomic and epidemiological insights that underpinned real-time public health responses. Kwok‑Yung Yuen [2] is associated with Université Paris-Sud [5] and Radboud University Nijmegen [6] during this era. His key contribution this era centers on the Clinical Characteristics of Coronavirus Disease 2019 in China [9], a clinical phenotyping paper that advanced risk stratification and informed integrated surveillance, diagnostics, and containment strategies.